Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The government is considering a separate licensing framework for bulk drugs, ac...
Dr. Reddy’s Laboratories announced the launch of Hevaxin, a novel recombinant v...
India’s healthcare and pharmaceutical industries stand at an inflection point. ...
The approval provides a new treatment option for this rare condition, which is l...
The first-in-class, subcutaneously administered hepcidin mimetic peptide, rusfer...
Pharmaceutical firms may no longer have to appear in courts in case of “certain...
When the Central Drugs Standard Control Organization (CDSCO) revised Good Manuf...
Pandorum Technologies, a clinical-stage regenerative medicine company building ...
What inspired you to write The Dual Mandate in B2B, and how is it different fro...
The leadership of Pharmaceuticals Export Promotion Council of India (PHARMEXCIL...
The partnership combines Insilico’s AI drug discovery platforms with Servier’s e...
The company has assumed commercial rights for Byooviz from Biogen, and the produ...
India’s pharmaceutical sector has continued to attract sustained investor inter...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) convened it...
Ethiopia is undergoing significant evolution in its pharma regulatory landscape...
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders dis...